SCHEMBL7220060

SCHEMBL7220060

CCCn1c(=O)c2[nH]c(-c3ccc(C=CC(=O)Nc4ccccc4C(C)=O)cc3)nc2n(CCC)c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 18/20 1.00
▸ ADORA3 P0DMS8 8/20 1.00
▸ ADORA2A P29274 9/20 0.69
▸ ADORA1 P30542 5/20 0.69
▸ KDM4E B2RXH2 2/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ HSD17B10 Q99714 2/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ GLA P06280 1/20 0.52
▸ HPGD P15428 1/20 0.52
▸ TSHR P16473 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7220057 1.00 ADORA2B (1.00) ADORA2BADORA3ADORA2AADORA1KDM4E
SCHEMBL7228404 0.88 ADORA2B (0.79) ADORA2BADORA3ADORA2AADORA1KDM4E
SCHEMBL7228400 0.88 ADORA2B (0.79) ADORA2BADORA3ADORA2AADORA1KDM4E
SCHEMBL7229028 0.85 ADORA2B (0.74) ADORA2BADORA3ADORA2AADORA1KDM4E
SCHEMBL7229037 0.85 ADORA2B (0.74) ADORA2BADORA3ADORA2AADORA1KDM4E
SCHEMBL7738379 0.82 ADORA2B (1.00) ADORA2BADORA3ADORA2AADORA1KDM4E
SCHEMBL30741228 0.82 ADORA2B (1.00) ADORA2BADORA3ADORA2AADORA1KDM4E
SCHEMBL1223882 0.81 ADORA2B (1.00) ADORA2BADORA3ADORA2AADORA1KDM4E
SCHEMBL27841466 0.76 ADORA2B (0.88) ADORA2BADORA3ADORA2AADORA1KDM4E
SCHEMBL1948455 0.75 ADORA2B (1.00) ADORA2BADORA3ADORA2AADORA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545002-B1 Treating asthma, diarrhea, insulin resistance, diabetes, ischemia/reprefusion injuries, diabetic retinopathy or hyperbaric oxygen-induced retinopathy UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2003-04-08 — — US disclosed
Send feedback